Profile data is unavailable for this security.
About the company
Novogene Co Ltd is a China-based company principally engaged in gene sequencing. The Company mainly relies on high-throughput sequencing technology and bioinformatics analysis technology to establish gene sequencing platforms. Combined with multi-omics research technology, the Company provides multi-level scientific and research technical services and solutions for life science basic research, medical and clinical application research. Based on the technology accumulation in gene sequencing and its application fields, the Company independently develops genetic testing medical equipment. The Company's services mainly include life science basic scientific research services, medical research and technical services, and database-building sequencing platform services. Its other services and products include gene mutation detection kits, coronavirus disease nucleic acid test service and DA8600 sequencers. The Company conducts its businesses in domestic and overseas markets.
- Revenue in CNY (TTM)2.17bn
- Net income in CNY175.21m
- Incorporated2011
- Employees2.20k
- LocationNovogene Co Ltd101, Block 301, No.10A JiuxianqiaoNorth Road, Chaoyang DistrictBEIJING 100015ChinaCHN
- Phone+86 1 082837801
- Fax+86 1 082837867
- Websitehttps://cn.novogene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Model Organisms Center Inc | 419.09m | 48.46m | 3.58bn | 731.00 | 76.34 | 2.04 | -- | 8.55 | 0.6018 | 0.6018 | 5.27 | 22.51 | 0.2217 | 11.60 | 3.33 | 573,313.10 | 2.56 | 1.15 | 2.79 | 1.28 | 51.30 | 48.18 | 11.56 | 5.65 | 7.35 | -- | 0.0236 | 46.61 | 4.01 | 19.75 | 131.56 | -22.51 | 63.43 | -- |
| Wuxi Commercial Mansion Grand Orient Co | 3.53bn | -1.54m | 3.72bn | 2.43k | -- | 1.17 | -- | 1.05 | -0.0015 | -0.0015 | 3.99 | 3.58 | 0.636 | 10.65 | 42.66 | 1,454,090.00 | 0.9026 | 4.32 | 1.33 | 7.24 | 15.73 | 14.71 | 1.42 | 5.61 | 0.4426 | 2.58 | 0.2229 | 83.24 | 3.08 | -17.20 | -72.97 | -27.84 | -22.49 | -30.12 |
| Zhongzhu Healthcare Holding Co Ltd | 570.62m | -561.59m | 5.28bn | 1.25k | -- | 3.08 | -- | 9.26 | -0.2818 | -0.2818 | 0.2869 | 0.8612 | 0.2418 | 1.48 | 7.09 | 457,960.80 | -23.93 | -10.17 | -27.66 | -11.99 | 10.19 | 11.79 | -98.97 | -65.53 | 3.07 | -2.40 | 0.0049 | -- | -18.35 | -5.62 | -80.33 | -- | -55.87 | -- |
| Novogene Co Ltd | 2.17bn | 175.21m | 6.36bn | 2.20k | 35.57 | 2.38 | -- | 2.93 | 0.4295 | 0.4295 | 5.34 | 6.41 | 0.6045 | 5.53 | 3.03 | 986,773.00 | 5.00 | 5.80 | 7.06 | 8.99 | 42.95 | 41.83 | 8.27 | 8.85 | 2.35 | -- | 0.0246 | 10.14 | 5.45 | 6.59 | 10.52 | 11.48 | 1.13 | -- |
| Shanghai InnoStar Bio-tech Co Ltd | 829.92m | 204.44k | 7.94bn | 1.09k | 251.72 | 3.40 | -- | 9.56 | 0.2236 | 0.2236 | 7.08 | 16.58 | 0.2579 | 1.49 | 2.37 | 764,906.00 | 0.5214 | -- | 0.6545 | -- | 26.96 | -- | 2.02 | -- | 2.71 | -- | 0.0501 | -- | 9.94 | -- | -24.00 | -- | -- | -- |
| Nanjing Xinjiekou Department Store CoLtd | 6.60bn | 220.90m | 9.32bn | 20.45k | 42.02 | 0.527 | -- | 1.41 | 0.1649 | 0.1649 | 4.81 | 13.15 | 0.2531 | 5.53 | 4.89 | 322,760.40 | 1.29 | 3.11 | 1.82 | 4.41 | 41.76 | 50.26 | 5.10 | 12.43 | 1.38 | -- | 0.052 | 4.89 | 1.98 | -6.75 | -46.10 | -32.87 | -0.475 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 6.22m | 1.50% |
| Harfor Fund Management Co., Ltd.as of 30 Jun 2025 | 2.77m | 0.67% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 1.05m | 0.25% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 704.35k | 0.17% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 676.76k | 0.16% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 672.55k | 0.16% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 553.80k | 0.13% |
| Gowin Asset Management Co. Ltd.as of 30 Jun 2025 | 429.37k | 0.10% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2025 | 388.98k | 0.09% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 333.98k | 0.08% |
